Sofosbuvir/velpatasvir/voxilaprevir Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with sofosbuvir/velpatasvir/voxilaprevir
V
- Valturna (aliskiren / valsartan)
- Velivet (desogestrel / ethinyl estradiol)
- Velosulin BR (insulin regular)
- Vemlidy (tenofovir alafenamide)
- vemurafenib
- VeraRing (ethinyl estradiol / etonogestrel)
- Vestura (drospirenone / ethinyl estradiol)
- Viberzi (eluxadoline)
- Victoza (liraglutide)
- Victrelis (boceprevir)
- Vida Mia Pain Relief (aspirin/citric acid/sodium bicarbonate)
- Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
- Vienva (ethinyl estradiol / levonorgestrel)
- Vimovo (esomeprazole / naproxen)
- Viorele (desogestrel / ethinyl estradiol)
- Viramune (nevirapine)
- Viramune XR (nevirapine)
- Viread (tenofovir)
- Virtrate-2 (citric acid/sodium citrate)
- Virtrate-3 (citric acid/potassium citrate/sodium citrate)
- Vitetal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Volnea (desogestrel / ethinyl estradiol)
- Vonjo (pacritinib)
- Votrient (pazopanib)
- Vyfemla (ethinyl estradiol / norethindrone)
- VyLibra (ethinyl estradiol / norgestimate)
- Vytorin (ezetimibe / simvastatin)
- Vyxeos (cytarabine liposomal / daunorubicin liposomal)
More about sofosbuvir / velpatasvir / voxilaprevir
- sofosbuvir/velpatasvir/voxilaprevir consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.